STOCK TITAN

RISE GOLD CORP Form 4 Filings

RYES OTC

Every Form 4 that RISE GOLD CORP (RYES) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A Form 4 covers the transactions officers, directors and large holders report, so if you follow RYES and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full RYES filings page.

Rhea-AI Summary

Rise Gold Corp. CEO and President David George Watkinson reported equity compensation changes. He received a grant of 62,500 shares of Common Stock at $0.00 per share upon settlement of fully vested RSUs, increasing his direct Common Stock holdings to 375,000 shares. He also received a new fully vested award of 62,500 RSUs, each convertible into one share of Common Stock. In addition, he continues to hold stock options over 1,110,000 underlying Common shares at exercise prices between $0.10 and $0.25, expiring in 2030.

Rhea-AI Summary

Rise Gold Corp. CEO and President David George Watkinson reported equity compensation adjustments involving common stock, RSUs, and stock options. On April 1, 2026, he acquired 62,500 shares of common stock at $0.0000 per share, received upon vesting of RSUs, bringing his direct common share holdings to 312,500 shares. A matching block of 62,500 RSUs was disposed of to the issuer as they converted into common stock, and he was granted a new award of 62,500 RSUs, each representing the right to receive one share of common stock upon vesting. He also continues to hold stock options over 60,000 shares at an exercise price of $0.10 expiring in 2030, 50,000 shares at $0.25 expiring in 2030, and 1,000,000 shares at $0.18 expiring in 2030, all on a direct basis.

Rhea-AI Summary

Rise Gold Corp. CEO and President David George Watkinson reported compensation-related equity movements. He received a grant of 62,000 shares of Common Stock at a price of $0.0000 per share, bringing his direct Common Stock holdings to 312,000 shares after the transaction.

On the same date, 62,000 Restricted Stock Units (RSUs) were disposed of to the issuer and a new award of 62,000 RSUs was recorded. Footnotes state that the RSUs are fully vested on the grant date and each vested RSU entitles the holder to one share of Common Stock, which were acquired as reported.

Watkinson also holds stock options over Common Stock, including 60,000 underlying shares at an exercise price of $0.1000, 50,000 underlying shares at $0.2500, and 1,000,000 underlying shares at $0.1800, with expirations in 2030.

Rhea-AI Summary

Rise Gold Corp. CEO and President David George Watkinson reported equity compensation changes involving 250,000 shares. On January 5, 2026 he received 250,000 Restricted Stock Units (RSUs), fully vested on the grant date, each RSU representing one share of common stock.

On January 6, 2026 these 250,000 RSUs were disposed to the issuer and converted into 250,000 shares of common stock, which he now holds directly. He also retains stock options over 1,000,000 shares at $0.18, 50,000 shares at $0.25, and 60,000 shares at $0.10, all expiring in 2030.

Rhea-AI Summary

Rise Gold Corp. CEO and President David George Watkinson reported a grant of stock options for 1,000,000 shares of common stock. These options were awarded on November 20, 2025 with an exercise price of 0.18 per share and expire on November 20, 2030.

After this grant, he also holds stock options linked to 50,000 shares at an exercise price of 0.25 expiring on October 30, 2030, and options linked to 60,000 shares at an exercise price of 0.10 expiring on May 22, 2030, all as direct holdings.

Rhea-AI Summary

Rise Gold Corp. CEO and President David Watkinson reported equity compensation and a related share issuance. On January 5, 2026, he received 250,000 restricted stock units (RSUs), which the footnotes state were fully vested on the grant date, with each RSU representing the right to receive one share of common stock when vested. On January 6, 2026, these 250,000 RSUs were converted into 250,000 shares of common stock at a stated price of $0.00, reflecting a non-cash conversion of awards. Following this transaction, he directly beneficially owned 250,000 common shares. The filing also shows a holding of 1,000,000 stock options with an exercise price of $0.18 per share and an expiration date of November 20, 2030, reported as a continuing position rather than a new grant.

Rhea-AI Summary

Rise Gold Corp. reported an insider equity award for its CEO and President, who also serves as a director. On 11/20/2025, the executive received stock options covering 1,000,000 derivative securities, each representing one share of Rise Gold common stock. The options have an exercise price of $0.18 per share, became exercisable on 11/20/2025, and are scheduled to expire on 11/20/2030. Following this transaction, the executive directly beneficially owned 1,000,000 derivative securities.

Rhea-AI Summary

Rise Gold Corp. (RYES) insider Daniel Oliver, a director and 10% owner, reported his equity and derivative holdings in a Form 4. On 11/20/2025, he received options to buy 1,000,000 shares of common stock at an exercise price of $0.18 per share, exercisable through 11/20/2030. Following the reported transactions, he directly holds 1,210,653 common shares and indirectly holds 14,663,191 shares through Myrmikan Gold Fund, LLC.

The filing also lists multiple options and warrants with exercise prices ranging from $0.10 to $0.45, plus 365,854 Deferred Share Units that convert into common stock when he ceases to be an eligible person under the company’s long-term plan. Certain warrants are subject to a standstill agreement, under which the holder has agreed not to exercise them unless the agreement is terminated with 61 days’ written notice, and some warrants were issued in connection with a $500,000 secured loan to the company.

Rhea-AI Summary

Rise Gold Corp. (RYES) director Lawrence W. Lepard filed a Form 4 reporting his equity holdings and a new option grant. On 11/20/2025, he received options to purchase 150,000 shares of common stock at an exercise price of $0.18 per share, exercisable on that same date and expiring on 11/20/2030. After this transaction, he holds common shares directly and also indirectly through EMA GARP FUND LP, Sea View Investments, LLC, and for the benefit of his children. He also reports multiple previously granted options and warrants with exercise prices ranging from $0.10 to $0.65 and expirations between 2027 and 2030, highlighting his ongoing equity-linked exposure to the company.

Rhea-AI Summary

Rise Gold Corp. (RYES) reported an insider equity award for director Clynton R. Nauman. On 11/20/2025, he received 150,000 stock options with an exercise price of $0.18 per share, exercisable immediately and expiring on 11/20/2030. The filing also shows he holds other previously granted stock options on common stock at exercise prices ranging from $0.10 to $0.26 with expirations between 2028 and 2030. Following the reported transactions, he beneficially owns 166,666 shares of Rise Gold common stock directly.

Rhea-AI Summary

Rise Gold Corp. (RYES) director Thomas I. Vehrs reported insider transactions on a Form 4. On 11/20/2025, he disposed of 25,000 shares of Rise Gold common stock. The filing also shows he was granted 150,000 stock options with an exercise price of $0.18 per share, which are exercisable on 11/20/2025 and expire on 11/20/2030. The form lists several additional direct option holdings at exercise prices between $0.10 and $0.65, with expiration dates ranging from 02/07/2027 to 10/30/2030, giving insight into his long-term equity-based compensation and ownership structure.

Rhea-AI Summary

Rise Gold Corp. (RYES) Chief Financial Officer Mihai Draguleasa filed a Form 4 reporting equity awards and holdings. On 11/20/2025, he received 70,000 stock options with an exercise price of $0.18 per share, exercisable immediately and expiring on 11/20/2030, each linked to one share of common stock. The filing also lists previously granted stock options at exercise prices of $0.25 and $0.10 with expirations in 2030, along with 60,976 warrants at $0.15 expiring in 2028. In addition, 121,952 shares of common stock and certain warrants are reported as indirectly owned through Lazuli CPA Inc.

Rhea-AI Summary

Rise Gold (RYES) President and CEO Joseph Mullin filed a Form 4 detailing equity awards and holdings. He reported 1,000,000 Deferred Share Units (DSUs) granted on 10/30/2025 at $0.00, fully vested on the grant date, subject only to approval of the Long‑Term Incentive Plan at the annual general meeting to be held on 11/19/2025. Each DSU entitles the holder to one common share upon ceasing to be an Eligible Person under the plan.

He also reported option positions held indirectly by Mount Arvon Partners LLC, including 530,469 options at $0.25 exercisable 10/30/2025 and expiring 10/30/2030, plus previously awarded options such as 2,790,000 at $0.10 expiring 05/22/2030 and additional tranches expiring in 2029–2030. Warrant positions include 80,000 at $0.45 expiring 10/24/2028 and other series expiring 2025–2028. Following the reported transactions, he directly held 701,095 common shares.

Rhea-AI Summary

Rise Gold Corp. (RYES) reported an insider transaction on a Form 4. On 10/30/2025, a director acquired 100,000 stock options at an exercise price of $0.25, exercisable on 10/30/2025 and expiring on 10/30/2030. Following the reported transactions, the insider holds 166,666 shares of common stock directly. The filing also lists previously held derivatives, including options of 60,000 (expiring 05/22/2030), 60,000 (03/25/2030), 15,000 (05/01/2029), 47,775 (12/12/2028), 94,070 (09/22/2028), and warrants of 83,333 (11/07/2025).

Rhea-AI Summary

Rise Gold Corp. (RYES) insider Daniel Oliver, a director and 10% owner, filed a Form 4 reporting equity awards and updated holdings. On 10/30/2025, he reported 365,854 Deferred Share Units (DSUs) at $0.00 and an option grant for 300,000 shares at an exercise price of $0.25 expiring on 10/30/2030. Prior awards listed include options of 200,000 at $0.10 (05/22/2025–05/22/2030), 60,000 at $0.10 (03/25/2025–03/25/2030), 15,000 at $0.17 (05/01/2024–05/01/2029), and 200,000 at $0.25 (12/12/2023–12/12/2028), along with multiple warrants.

Following the transactions, reported beneficial ownership shows 1,210,653 shares direct and 14,663,191 shares indirect via Myrmikan Gold Fund, LLC. The filing notes a warrant standstill agreement (as amended on 05/08/2025 and 10/24/2025) under which the holder agreed not to exercise specified warrants; it may be terminated on 61 days' written notice. The DSUs are fully vested on grant, subject to approval of the company’s Long-Term Incentive Plan at the annual meeting on 11-19-25.

Rhea-AI Summary

Rise Gold Corp. (RYES) director Thomas I. Vehrs filed a Form 4 reporting an equity award. On 10/30/2025, he acquired 100,000 stock options with a $0.25 exercise price, exercisable 10/30/2025 and expiring 10/30/2030. Ownership is reported as Direct.

The filing also lists previously granted options outstanding in multiple tranches, including 105,000 options at $0.53 expiring 02/21/2028 and 100,000 options at $0.65 expiring 02/07/2027.

Rhea-AI Summary

Rise Gold (RYES) reported insider activity by director Lawrence W. Lepard. On 10/30/2025, he acquired 100,000 stock options at an exercise price of $0.25, exercisable on 10/30/2025 and expiring 10/30/2030. Following the filing, he reports 977,405 common shares held directly, plus indirect holdings including 2,559,656 via EMA GARP FUND LP and 904,000 via Sea View Investments, LLC.

Rhea-AI Summary

Rise Gold (RYES) reported an insider equity update. On 10/30/2025, the company’s Chief Financial Officer acquired 75,000 stock options at an exercise price of $0.25, exercisable on 10/30/2025 and expiring on 10/30/2030.

The filing also lists existing derivative holdings: stock options of 60,000 (exercisable 05/22/2025; expire 05/22/2030) and 60,000 (exercisable 03/25/2025; expire 03/25/2030) at $0.10, plus 60,976 warrants at $0.15 (exercisable 05/08/2025; expire 05/08/2028) held indirectly by Lazuli CPA Inc. Non‑derivative common stock beneficially owned is 121,952 shares, held indirectly by Lazuli CPA Inc.

Rhea-AI Summary

Rise Gold (RYES): Director and 10% owner Daniel Oliver reported buying 1,000,000 shares of common stock at $0.25 on 10/24/2025. Following the transaction, beneficial ownership was 14,663,191 shares held indirectly through Myrmikan Gold Fund, LLC and 1,210,653 shares held directly.

On the same date, the reporting persons also reported 1,000,000 new warrants with a $0.45 exercise price, held indirectly via Myrmikan Gold Fund, alongside previously reported options and warrants positions. A warrant standstill agreement dated 4/9/2024, as amended on 5/8/2025 and 10/24/2025, provides that the holder has agreed not to exercise specified warrants and may terminate the standstill with 61 days’ written notice; under this, the holder does not beneficially own the warrant underlying shares for Section 13(d) purposes. One prior warrant issuance was tied to a $500,000 secured loan to the issuer.

Rhea-AI Summary

Rise Gold (RYES): An insider group led by Equinox Partners Investment Management LLC and Sean M. Fieler reported open‑market purchases on 10/24/2025. Across affiliated vehicles, they acquired 5,600,000 shares at $0.25 per Unit, with each Unit consisting of one common share and one warrant.

The newly issued warrants are exercisable at $0.45 and expire on 10/24/2028. Post‑transaction, the filing lists updated beneficial holdings for each account, and also shows existing warrants with a $0.15 exercise price expiring on 05/08/2028. The warrants include a 19.99% Beneficial Ownership Limitation, which can be terminated by the holder with at least 61 days’ prior notice. The reporting persons disclaim beneficial ownership beyond their pecuniary interest.

Rhea-AI Summary

Rise Gold Corp. (RYES) President and CEO Joseph Mullin reported buying 80,000 common shares at $0.25 on 10/24/2025, bringing his direct holdings to 701,095 shares.

He also acquired warrants for 80,000 shares with a $0.45 exercise price, expiring 10/24/2028. Additional holdings include indirect options via Mount Arvon Partners LLC covering 2,790,000 shares (to 05/22/2030), plus option grants for 812,410 (to 03/25/2030), 1,006,750 (to 09/19/2029), and 412,241 shares (to 05/01/2029). He also reports warrants of 121,951 (to 05/08/2028), 105,263 (to 04/09/2027), and 83,333 shares (to 11/07/2025).

Rhea-AI Summary

Mihai Draguleasa, Chief Financial Officer of Rise Gold Corp. (RYES), reported multiple acquisitions of company securities in May 2025. The filing shows 121,952 shares held indirectly through Lazuli CPA Inc. and two separate stock option grants/exercises of 60,000 options each with a $0.10 exercise price and 05/22/2025 and 03/25/2025 exercise/award dates. A warrant for 60,976 shares with a $0.15 strike and 05/08/2025 issuance is also reported.

Rhea-AI Summary

Mihai Draguleasa, Chief Financial Officer of Rise Gold Corp. (RYES), reported insider purchases on 05/08/2025. The filing shows an indirect purchase of 121,952 common shares at $0.082 per share through Lazuli CPA Inc., plus acquisition of 60,976 warrants at a $0.15 exercise price (expiring 05/08/2028). Additionally, 60,000 stock options with a $0.10 exercise price (expiring 03/25/2030) are reported as disposed of. The ownership after the transactions is 121,952 shares indirect. The form is signed on 10/10/2025.

Rhea-AI Summary

Rise Gold Corp. (RYES) reported a Form 4 showing that Mihai Draguleasa, the company's Chief Financial Officer and a director, acquired 60,000 common shares by exercising stock options on 03/25/2025. The options had an exercise price of $0.10 per share, were exercisable on 03/25/2025, and expire on 03/25/2030. After the transaction the reporting person directly beneficially owns 60,000 shares. The Form 4 is signed on 10/10/2025.